Skip to main content
Equibles

Beneficial ownership — 13D / 13G

85,680 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.

Reporting person Issuer Schedule % of class Filed
GIC Private Ltd MEKA MELI Kaszek Pioneer Corp Class A Ordinary Shares 13G/A 0% 2y
DAVIDSON KEMPNER PARTNERS USCT Roth CH Acquisition Co. Class A Ordinary Shares 13G/A 0% 2y
Islet Management, LP TBCH Turtle Beach Corp 13G/A 1.2% 2y
FEDERATED HERMES, INC. ARCT Arcturus Therapeutics Holdings Inc. 13G/A 17.63% 2y
ATTICUS WEALTH MANAGEMENT, LLC AAPY NEOS ETF Trust 13G 10% 2y
KPartners Limited TC Token Cat Ltd 13G/A 4.5% 2y
KPartners Limited HERE Here Group Ltd 13G 13.8% 2y
FEDERATED HERMES, INC. AMPH Amphastar Pharmaceuticals, Inc. 13G/A 6.83% 2y
ADK Soho Fund LP QMCO Quantum Corp 13G/A 9.8% 2y
Islet Management, LP GRPN Groupon, Inc. 13G/A 0.2% 2y
MILLENNIUM MANAGEMENT LLC ESPR Esperion Therapeutics, Inc. 13G/A 3.2% 2y
ELLINGTON MANAGEMENT GROUP LLC SIVB SVB Financial Group 13G/A 8.56% 2y
Scorpio Holdings Limited CDLR Cadeler plc 13D 12.09% 2y
Muthusamy Shanmugam ANIP Ani Pharmaceuticals Inc 13D/A 4.8% 2y
Carlos G. Bonilla SRTM Stratum Holdings Corp. 13G 8.3% 2y
Soo Kow Lai BGLC BioNexus Gene Lab Corp 13D 7.03% 2y
Dean Kehler NB Niocorp Developments Ltd 13D 9.3% 2y
GLENVIEW CAPITAL MANAGEMENT, LLC ALIT Alight, Inc. / Delaware 13G 5% 2y
Bloom Retirement Holdings Inc. FOA Finance of America Companies Inc. 13D/A 9.49% 2y
HG Vora Capital Management, LLC PENN PENN Entertainment, Inc. 13D/A 9.6% 2y
Amit Kumar ANIX Anixa Biosciences Inc 13D/A 13.5% 2y
Saba Capital Management, L.P. GNT GAMCO Natural Resources, Gold & Income Trust 13D 8.9% 2y
Nabors Lux 2 S.a.r.l. VSTE Vast Renewables Limited Ordinary Shares 13D/A 31.8% 2y
Saba Capital Management, L.P. ASGI abrdn Global Infrastructure Income Fund 13D 9.18% 2y
Juweel Investors (SPC) Ltd GBTG Global Business Travel Group, Inc. 13D/A 0% 2y
BIOTECHNOLOGY VALUE FUND L P XOMA XOMA Royalty Corp 13D/A 31.6% 2y
Abdiel Qualified Master Fund, LP CRCT Cricut, Inc. 13G/A 12% 2y
AMERICAN EXPRESS CO GBTG Global Business Travel Group, Inc. 13D/A 33.8% 2y
Expedia Group, Inc. GBTG Global Business Travel Group, Inc. 13D/A 16% 2y
Li Ka Shing NXE NexGen Energy Ltd. 13D/A 2.85% 2y
Restaurant Brands International Inc. (IRS Identification Number ) TAST Carrols Restaurant Group, Inc. 13D/A 14.6% 2y
Lynrock Lake LP ONTF ON24 INC. 13D/A 17.7% 2y
BML Investment Partners, L.P. ACRS Aclaris Therapeutics, Inc. 13G 6.4% 2y
MAK CAPITAL ONE LLC AGYS Agilysys Inc 13D/A 12.6% 2y
Runa Capital Opportunity I (GP) MRDB MariaDB plc 13D/A 4% 2y
JENKINS DAVID A VJET Flyte Aviation, Inc. 13D/A 14.1% 2y
TCG Crossover GP II, LLC ATXS Astria Therapeutics, Inc. Common Stock 13G 9.9% 2y
James J. Pallotta MAPS Wm Technology, Inc. 13G 5.3% 2y
GABELLI MARC MPTI M-tron Industries, Inc. 13D/A 2.45% 2y
Xing Jin SY So-Young International Inc. 13D 17.7% 2y
Avidity Partners Management LP IMUX Immunic, Inc. 13G 9.9% 2y
Legend Aggregator, LP LQDA Liquidia Corp 13G 9.5% 2y
Slotting RemainCo Limited Partnership FET Forum Energy Technologies, Inc. 13G 7.2% 2y
IV Global Fund No. 4 DZSI DZS Inc. Common Stock 13D 14.5% 2y
SINGER JAMES R VERV Verve Therapeutics, Inc. Common Stock 13G/A 3.7% 2y
Gabelli Equity Series Funds, Inc. - The Gabelli Small Cap Growth Fund I.D. No. STRT Strattec Security Corp 13G/A 6.22% 2y
MILLENNIUM MANAGEMENT LLC XFOR X4 Pharmaceuticals, Inc 13G/A 1% 2y
KORNITZER CAPITAL MANAGEMENT INC /KS LARK Landmark Bancorp Inc 13G/A 6.98% 2y
MILLENNIUM MANAGEMENT LLC DBI Designer Brands Inc. 13G/A 0.3% 2y
MILLENNIUM MANAGEMENT LLC INZY Inozyme Pharma, Inc. Common Stock 13G/A 1.5% 2y